NORINCHUKIN BANK, THE – Vertex Pharmaceuticals Incorporated Transaction History
NORINCHUKIN BANK, THE portfolio value:
$6.97M
portfolio value
NORINCHUKIN BANK, THE quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +11.27% | 2.43K shares | 874K | $289.54 | 24.07K |
Q2 2022 | share | Decrease | -17.90% | -4.71K shares | -781K | $281.79 | 21.63K |
Q1 2022 | share | Increase | +10.40% | 2.48K shares | 1.63M | $260.97 | 26.35K |
Q4 2021 | share | Decrease | -7.44% | -1.91K shares | 564K | $222.45 | 23.87K |
Q3 2021 | share | Increase | +5.73% | 1.39K shares | -240K | $181.39 | 25.79K |
Q2 2021 | share | Increase | +0.90% | 217 shares | -277K | $201.63 | 24.39K |
Q1 2021 | share | Increase | +4.93% | 1.13K shares | -250K | $214.89 | 24.17K |
Q4 2020 | share | Decrease | -0.57% | -132 shares | -860K | $236.34 | 23.04K |
Q3 2020 | share | Increase | +3.47% | 778 shares | -196K | $272.12 | 23.17K |
Q2 2020 | share | Increase | +0.04% | 9 shares | 1.17M | $290.31 | 22.39K |
Q1 2020 | share | Decrease | -35.68% | -12.42K shares | -2.29M | $237.95 | 22.38K |
Q4 2019 | share | Decrease | -7.95% | -3.00K shares | 1.21M | $218.95 | 34.80K |
Q3 2019 | share | Increase | +2.73% | 1.00K shares | -344K | $169.42 | 37.81K |
Q2 2019 | share | Decrease | -25.26% | -12.44K shares | -2.30M | $183.38 | 36.81K |
Q1 2019 | share | Increase | +3.63% | 1.72K shares | 1.18M | $183.95 | 49.25K |
Q4 2018 | share | Increase | +44.59% | 14.65K shares | 1.54M | $165.71 | 47.52K |
Q3 2018 | share | Increase | +13.85% | 3.99K shares | 1.42M | $192.74 | 32.87K |
Q2 2018 | share | Increase | +24.10% | 5.60K shares | 1.11M | $169.96 | 28.87K |
Q1 2018 | share | Increase | +15.07% | 3.04K shares | 762K | $162.98 | 23.26K |
Q4 2017 | share | Increase | +7.75% | 1.45K shares | 177K | $149.86 | 20.21K |
Q3 2017 | share | Increase | +8.57% | 1.48K shares | 626K | $152.04 | 18.76K |
Q2 2017 | share | Increase | +7.06% | 1.14K shares | 462K | $128.87 | 17.28K |
Q1 2017 | share | Increase | +7.29% | 1.09K shares | 656K | $109.35 | 16.14K |
Q4 2016 | share | Increase | +13.43% | 1.78K shares | -48K | $73.67 | 15.04K |
Q3 2016 | share | Increase | +2.25% | 292 shares | 41K | $87.21 | 13.26K |
Q2 2016 | share | Increase | +2.60% | 329 shares | 111K | $86.02 | 12.97K |
Q1 2016 | share | Increase | +10.16% | 1.16K shares | -439K | $79.49 | 12.64K |